Policy and Advocacy News
-
amfAR’s Greg Millett Presents at Smithsonian World AIDS Day Event
amfAR vice president and director of public policy Greg Millett took part in a World AIDS Day program sponsored by the Smithsonian’s National Museum of Natural History on December 3, 2020. Millett spoke in a segment covering laws and policies affecting people with HIV.
-
Biden Releases Updated National HIV/AIDS Strategy
At a World AIDS Day event at the White House, President Biden announced the release of an updated National HIV/AIDS Strategy and recommitted the United States to ending AIDS as a public health threat by 2030.
-
Stark Inequities Continue to Undermine U.S. HIV Response
Unequal access to prevention and care, stigma drive worrying trends for Black and Latino gay men.
-
FDA Approves Long-Acting Injectable to Treat HIV
A long-acting-acting HIV treatment consisting of two shots monthly has been approved by the U.S. Food & Drug Administration (FDA) for adults with suppressed virus currently on a stable antiretroviral regimen.
-
amfAR’s Greg Millett Presents on 40th Anniversary of HIV/AIDS
amfAR vice president and director of public policy Greg Millett took part in a virtual webinar and conversation with senior federal officials and community leaders on the 40th anniversary of HIV/AIDS on Tuesday, June 15, 2021. Greg discussed how HIV has changed the world, and similarities between COVID-19 and HIV.
-
U.S. Sees Progress on HIV, Room for Improvement
A series of reports released by the Centers for Disease Control and Prevention (CDC), May 27, show “hopeful signs of progress” but point to some areas in which progress continues to lag. The reports, which use CDC surveillance data, all cover the five-year period 2015 to 2019.
-
A Neglected Population: Transgender Inclusion in National HIV Plans
Worldwide, transgender people are disproportionately impacted by HIV, but historically overlooked in HIV National Strategic Plans (NSPs).
-
People Living with HIV Should Be Prioritized for Coronavirus Vaccine
As coronavirus vaccine distribution gathers pace across the U.S., there is limited consensus and some confusion as to which populations should be prioritized for the vaccine.
-
amfAR Study Wins Elsevier Atlas Award
Study was first to rigorously quantify effects of coronavirus pandemic in Black communities nationally.
-
amfAR Launches New Ending the HIV Epidemic Database
The Ending the HIV Epidemic database is the latest in amfAR’s repertoire of visual tools to summarize the data in President Trump’s plan—Ending the HIV Epidemic—to end new HIV transmissions in the U.S. by 2030, zeroing in on the “geographic hotspots” of HIV.
-
amfAR’s Medication-Assisted Treatment Analysis Featured in New York Times